The english version of the website of the School of Medicine is under development

Δημοσίευση

Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report.

TitlePulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report.
Publication TypeJournal Article
Year of Publication2011
AuthorsPorpodis, K., Konoglou M., Zarogoulidis P., Kaimakamis E., Kontakiotis T., Papakosta D., Zervas V., Katsikogiannis N., Courcoutsakis N., Mitrakas A., Touzopoulos P., Karanikas M., Zarogoulidis K., & Markopoulou A.
JournalInt J Gen Med
Volume4
Pagination767-72
Date Published2011
ISSN1178-7074
Abstract

In recent years, there has been a major advance in the treatment of pulmonary hypertension. New medications are continually added to the therapeutic arsenal. The prostanoids are among the first agents used to treat pulmonary hypertension and are currently considered the most effective. This case study describes a 63-year-old man who was diagnosed with chronic thromboembolic pulmonary hypertension and successfully treated with subcutaneously administered treprostenil for 6 months before a successful pulmonary thromboendarterectomy. Treatment of chronic thromboembolic pulmonary hypertension often requires a multidisciplinary approach before surgery. Further evaluation of prostanoids is needed to define their role and time of initiation of medical therapy in these patients.

DOI10.2147/IJGM.S26494
Alternate JournalInt J Gen Med
PubMed ID22114523
PubMed Central IDPMC3219765

Contact

Secretariat of the School of Medicine
 

Connect

Schoole of Medicince presence in social networks
Follow Us or Connect with us.